MassMutual Private Wealth & Trust’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
MassMutual Private Wealth & Trust's MLYS Position: Q3 2026 in Review
MassMutual Private Wealth & Trust reduced its Mineralys Therapeutics (MLYS) stake by 30% in Q3 2026, selling an estimated $2.59K and leaving 224 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.
MassMutual Private Wealth & Trust first reported a position in MLYS in Q4 2023 and has held it in 12 quarters since. The position peaked at $12.1K in Q3 2025. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- MassMutual Private Wealth & Trust held 224 shares of Mineralys Therapeutics worth $5.63K as of Q3 2026.
- MassMutual Private Wealth & Trust sold 95 Mineralys Therapeutics shares in Q3 2026, an estimated $2.59K.
- Mineralys Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1575 holding.
- MassMutual Private Wealth & Trust first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 12 quarters since.
- MassMutual Private Wealth & Trust's Mineralys Therapeutics position peaked at $12.1K in Q3 2025.
- 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.